- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INSTINCT BIO TECHNICAL Aktie jetzt für 0€ handeln | |||||
| 16.10. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.10. | EQS-News: Instinct Bio Technical Company Holdings Inc.: Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026 | 487 | EQS Group (EN) | EQS-News: Instinct Bio Technical Company Holdings Inc.
/ Key word(s): Financial
Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal... ► Artikel lesen | |
| 01.10. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.09. | EQS-News: Instinct Bio Technical Company Holdings Inc.: BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China | 509 | EQS Group (EN) | EQS-News: Instinct Bio Technical Company Holdings Inc.
/ Key word(s): Financial
BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China 30.09.2026... ► Artikel lesen | |
| 15.09. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.09. | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.: Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market Value of Listed Securities and Publicly Held Shares | 423 | EQS Group (EN) | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
/ Key word(s): Financial
Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market... ► Artikel lesen | |
| 08.09. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.09. | Instinct Bio sichert Standort für Klinik in Jakarta und legt Abo-Preise fest | 1 | Investing.com Deutsch | ||
| 04.09. | Instinct Bio secures Jakarta clinic site, sets subscription tiers | 1 | Investing.com | ||
| 04.09. | Instinct Bio Technical Company Holdings Inc.: INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives | 328 | GlobeNewswire (Europe) | NEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today provided an operational update on the initiatives... ► Artikel lesen | |
| 10.08. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.07. | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.: Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER Into U.S. and Advance Indonesia Regenerative Medicine Initiatives | 662 | EQS Group (EN) | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
/ Key word(s): Healthcare
Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER... ► Artikel lesen | |
| 29.07. | Instinct Bio expandiert mit Abo-Modell für Schönheitskliniken nach Indonesien | 3 | Investing.com Deutsch | ||
| 29.07. | INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.: BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand "GENRÊVER CLINIC" | 646 | GlobeNewswire (Europe) | NEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ: BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese... ► Artikel lesen | |
| 29.07. | Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOT | 9 | Benzinga.com | ||
| 28.07. | Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth | 394 | GlobeNewswire (Europe) | New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC: (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today announced that it has entered into an indicative... ► Artikel lesen | |
| 28.07. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 23.07. | Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker "BIOT" on July 24, 2026 | 550 | GlobeNewswire (Europe) | New York, NY, Las Vegas, NV, Tokyo, JP, July 23, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. ("Instinct Bio," "BIOT," or the "Company"), the parent company of Instinct Bio... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,62 | +0,62 % | EQS-DD: Fresenius SE & Co. KGaA: Dr. Christian Pawlu, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
09.11.2026 / 09:49... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,110 | +1,39 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 38 auf 37,50 Euro gesenkt und die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,950 | +0,34 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Siemens Healthineers von 50 auf 55 Euro angehoben und die Einstufung auf "Buy" belassen. Das vierte Geschäftsquartal habe... ► Artikel lesen | |
| HEARTFLOW | 48,330 | -0,27 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| PROGYNY | 36,180 | 0,00 % | Rekorde bei Familienplanung: Progyny glänzt mit blitzsauberer Bilanz und massiven Rückkäufen | Hier an der Wall Street in New York wird oft das schnelle Geld gesucht. Doch die wahren Börsenperlen findet man häufig in lukrativen Nischen, in denen ein Unternehmen zum unverzichtbaren Marktführer... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,500 | 0,00 % | NSE - Starling Oncology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| BRIGHTSPRING HEALTH SERVICES | 71,21 | 0,00 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| GENEDX | 52,36 | -0,02 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| OTTOBOCK | 40,050 | +2,17 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): 9-Monatszahlen
Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort
12.11.2026 / 07:30 CET/CEST
Für den... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 11,500 | 0,00 % | RBC Capital reiterates Aveanna Healthcare stock rating at Outperform | ||
| NEUROPACE | 7,590 | +0,40 % | Warum die NeuroPace-Aktie heute um fast 40 % einbricht | ||
| BILLIONTOONE | 105,15 | 0,00 % | BillionToOne auf der Stifel Healthcare Conference 2026: Wachstumsdynamik gewinnt an Breite | ||
| LIFESTANCE HEALTH GROUP | 14,080 | 0,00 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| ECKERT & ZIEGLER | 15,340 | +5,79 % | EQS-News: Eckert & Ziegler SE: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen
Eckert & Ziegler: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt
12.11.2026 / 07:45 CET/CEST
Für... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,560 | +0,04 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
Das Unternehmen INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,190 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC finden Sie auf Wallstreet Online.